SANGAMO THERAPEUTICS, INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sangamo Therapeutics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.07M, a 54.9% decline year-over-year.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $18.1M, a 41.9% decline year-over-year.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $27.4M, a 13.5% decline from 2022.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $31.7M, a 3.96% decline from 2021.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $33M, a 28.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $27.4M -$4.29M -13.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $31.7M -$1.31M -3.96% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $33M +$7.25M +28.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $25.7M +$6.38M +33% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $19.3M +$4.65M +31.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $14.7M +$5.59M +61.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $9.09M -$5.97M -39.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $15.1M +$3.33M +28.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $11.7M +$2.53M +27.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $9.2M +$3.05M +49.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $6.15M +$808K +15.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-18
2012 $5.34M -$2.74M -33.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $8.08M +$263K +3.36% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 $7.82M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.